Avidity Partners Management’s SomaLogic Warrant SLGCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-65,999
Closed -$220K – 112
2021
Q4
$220K Hold
65,999
– – ﹤0.01% 95
2021
Q3
$228K Buy
+65,999
New +$203K 0.01% 104

Other funds holding SLGCW

Avidity Partners Management's SLGCW Position: Q1 2022 in Review

Avidity Partners Management sold out of SomaLogic Warrant (SLGCW) in Q1 2022, closing a stake of 65,999 shares — an estimated $220K sold.

Avidity Partners Management first reported a position in SLGCW in Q3 2021 and held it in 2 quarters. The position peaked at $228K in Q3 2021. 28 funds tracked by Wall St. Rank hold SLGCW as of Q1 2022.

  • Avidity Partners Management reported no remaining SomaLogic Warrant position as of Q1 2022 after selling out during the quarter.
  • Avidity Partners Management sold 65,999 SomaLogic Warrant shares in Q1 2022, an estimated $220K.
  • Avidity Partners Management first reported a position in SomaLogic Warrant in Q3 2021 and held it in 2 quarters.
  • Avidity Partners Management's SomaLogic Warrant position peaked at $228K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held SomaLogic Warrant as of Q1 2022.

Based on Avidity Partners Management's 13F filing for Q1 2022, filed 16 May 2022.